Complications of Midazolam‐Containing Versus Midazolam‐Free Analgosedation in Mechanically Ventilated Adult ICU Patients: A Systematic Review
Nursing in Critical Care · 2026-11 · 31 (6)
DOI: 10.1111/nicc.70759 ↗Abstract
ABSTRACT Background Intensive care unit (ICU) patients requiring mechanical ventilation (MV) frequently need analgosedation strategies that combine analgesia and sedation. Analgosedation, often administered with midazolam, is widely employed in middle and low‐income countries, but it carries a substantial risk of complications, particularly in older or comorbid patients. Acknowledging these complications is critical for patient safety and quality of care. Aim To examine complications associated with midazolam‐containing versus midazolam‐free analgosedation in mechanically ventilated adult intensive care unit patients. Study Design This systematic review was conducted according to the PRISMA guidelines. A comprehensive search of Scopus, MEDLINE (PubMed), and Web of Science identified randomized controlled trials (RCTs) published between 2015 and 2025. Studies meeting predefined eligibility criteria underwent risk‐of‐bias assessment using the Cochrane RoB2 tool. Results Nine RCTs were included. Midazolam‐containing analgosedation regimens were generally associated with prolonged mechanical ventilation, increased respiratory depression and higher incidence of neurological complications, particularly delirium. In contrast, midazolam‐free analgosedation regimens, especially those using short‐acting opioids, were associated with shorter mechanical ventilation duration and fewer haemodynamic incidents. ICU length of stay and healthcare costs favoured opioid‐only analgosedation protocols, although mortality findings were inconsistent across studies. Conclusions Compared with midazolam‐free analgosedation, midazolam‐containing analgosedation regimens in mechanically ventilated adult ICU patients are associated with a higher incidence of respiratory and neurological complications. Opioid‐only protocols appear to offer a more favourable complication profile and may facilitate earlier weaning and shorter ICU stays. These findings support cautious use of midazolam and emphasize the importance of individualized, goal‐directed analgosedation strategies. Relevance to Clinical Practice Enhancing critical care nursing staff's awareness of complications associated with different analgosedation regimens is essential to promote vigilant clinical monitoring, thereby reducing adverse events and supporting safer patient management.
EUVIMED